QT
CLPT icon

Quantbot Technologies’s ClearPoint Neuro CLPT Stock Holding History

Quantbot Technologies’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$289K Buy
16,182
+8,789
+119% +$110K 0.01% 1130
2026
Q1 		$67.3K Buy
7,393
+5,819
+370% +$73.5K ﹤0.01% 1377
2025
Q4 		$21.5K Buy
+1,574
New +$29.2K ﹤0.01% 1564
2022
Q2 		– Sell
-500
Closed -$5K – 1746
2022
Q1 		$5K Buy
+500
New +$4.55K ﹤0.01% 1523

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CFM
Compass Financial Management Tampa, Florida $829M AUM

Quantbot Technologies's CLPT Position: Q2 2026 in Review

Quantbot Technologies increased its ClearPoint Neuro (CLPT) stake by 119% in Q2 2026, buying an estimated $110K and bringing the position to 16,182 shares worth $289K. The position accounts for 0.01% of the portfolio, ranked #1130.

Quantbot Technologies first reported a position in CLPT in Q1 2022 and has held it in 4 quarters since. 129 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • Quantbot Technologies held 16,182 shares of ClearPoint Neuro worth $289K as of Q2 2026.
  • Quantbot Technologies bought 8,789 ClearPoint Neuro shares in Q2 2026, an estimated $110K.
  • ClearPoint Neuro made up 0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1130 holding.
  • Quantbot Technologies first reported a position in ClearPoint Neuro in Q1 2022 and has held it in 4 quarters since.
  • 129 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.